LifeMD (NASDAQ:LFMD) (NASDAQ: LFMD) is a U.S.-based telehealth company that delivers on-demand, membership-based virtual healthcare services. Through its digital platform and mobile applications, LifeMD connects patients with board-certified healthcare providers for diagnosis, treatment and ongoing management of a range of acute and chronic conditions. The company’s core offering centers on personalized care plans supported by prescription fulfillment, lab testing and prescription delivery services.
LifeMD’s service portfolio spans several specialty areas, including men’s health, hormonal therapy, weight management and primary care. Patients access virtual consultations, follow-up visits and medication management through a flat-fee membership model. Specialized programs address conditions such as erectile dysfunction, hair loss, thyroid disorders and metabolic health, while integrated pharmacy partnerships allow users to receive prescribed treatments directly at home.
Since its founding, LifeMD has expanded through strategic acquisitions of complementary telehealth businesses to broaden its clinical capabilities and patient reach. The company’s brands now encompass platforms focused on preventive care, chronic disease management and women’s health, creating a multi-specialty virtual care network. LifeMD serves patients across the United States and continually invests in digital technology to improve care coordination and patient engagement.
Headquartered in Florida, LifeMD went public in early 2021 and trades on the Nasdaq under the ticker LFMD. The company is led by a management team with deep experience in healthcare delivery, digital innovation and telemedicine. LifeMD continues to leverage its unified platform to address evolving consumer preferences for accessible, cost-effective virtual care.
